Delcath Systems, Inc. (DCTH) vs Phathom Pharmaceuticals, Inc. (PHAT)

A side-by-side comparison of Delcath Systems, Inc. and Phathom Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DCTH vs PHAT

growth of $100 · dividends reinvested · last 7y
DCTH -71.7% (-16.5%/yr)PHAT -72.8% (-17.0%/yr)DCTH compounded faster over this window
050100150200Start $100202120232025$28$27
DCTH PHAT

DCTH vs PHAT: by the numbers

  • •PHAT is the larger company ($542M vs $535M market cap).
  • •DCTH is profitable (0.56% net margin) while PHAT runs a net loss (-41.34%).

Metrics side by side

Valuation

MetricDCTHPHAT
P/E ratio1193.07N/A
P/S ratio5.612.26
P/B ratio4.42N/A
FCF yield3.27%N/A

Profitability

MetricDCTHPHAT
Gross margin87.05%82.92%
Operating margin-1.90%-91.36%
Net margin0.56%-41.34%
ROE0.44%N/A
ROIC-0.81%-23.45%

Growth (annualized)

MetricDCTHPHAT
Revenue CAGR (5Y)118.96%N/A
Total return CAGR (5Y)10.90%-26.93%

Frequently asked

Is DCTH or PHAT more profitable?
DCTH runs the higher net margin — DCTH at 0.56% versus PHAT at -41.34%.
How have DCTH and PHAT total returns compared?
Over the past 5 years, DCTH delivered 10.90% and PHAT delivered -26.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.